Yagi Yuriko, Kodama Ken, Momozane Toru, Kimura Yukio, Takeda Masashi, Kishima Hiroki
Department of Thoracic Surgery, Kinki Chuo Chest Medical Center, 1180 Nakazone-cho, Kita-ku, Sakai, Osaka, 591-8555, Japan.
Department of Thoracic Surgery, Yao Municipal Hospital, Osaka, Japan.
Surg Case Rep. 2020 Jan 13;6(1):16. doi: 10.1186/s40792-019-0768-5.
Chemoradiotherapy (CRT) is the standard treatment for c-stage IIIB non-small cell lung cancer (NSCLC); however, patients who respond to CRT are at risk of developing fatal complications such as massive hemoptysis or infection. In such cases, surgery is an alternative option. Currently, there are limited reports on surgery for complications arising during definitive CRT for locally advanced NSCLC. We report a case of hemoptysis after definitive CRT for c-T4N2M0 stage IIIB NSCLC that was successfully treated with lower bilobectomy combined with left atrial resection.
A 72-year-old man with c-T4N2M0 stage IIIB NSCLC with left atrial invasion developed hemoptysis during CRT, which was discontinued to control hemoptysis. Chest computed tomography revealed a regressed and cavitated tumor. Three weeks after discontinuation of CRT, surgery was performed to avoid fatal complications and secure radicality. We performed lower bilobectomy combined with partial left atrial resection, which was performed using an automatic tri-stapler. The bronchial stump was covered with an omental flap. The resected specimen pathologically showed complete response with fistula between the intermediate bronchus and necrotic cavity in the tumor. His postoperative course was uneventful, and the patient was disease free at 10 months after surgery.
We successfully performed surgery after definitive CRT in a patient with c-T4N2M0 stage IIIB NSCLC. Partial left atrial resection was safely performed with an automatic tri-stapler. A complete pathological response to CRT was achieved. In a case with a chance of complete (R0) resection, when the risk of developing fatal complications might outweigh the risk of post-CRT surgery perioperative complications, surgery should be considered as a treatment option.
放化疗(CRT)是c期IIIB期非小细胞肺癌(NSCLC)的标准治疗方法;然而,对CRT有反应的患者有发生致命并发症的风险,如大量咯血或感染。在这种情况下,手术是一种替代选择。目前,关于局部晚期NSCLC根治性CRT期间出现并发症的手术治疗的报道有限。我们报告一例c-T4N2M0期IIIB期NSCLC根治性CRT后咯血的病例,该病例通过下叶切除术联合左心房切除术成功治疗。
一名72岁男性,患有c-T4N2M0期IIIB期NSCLC并侵犯左心房,在CRT期间出现咯血,为控制咯血而停止CRT。胸部计算机断层扫描显示肿瘤退缩并形成空洞。停止CRT三周后,进行手术以避免致命并发症并确保根治性。我们进行了下叶切除术联合部分左心房切除术,使用自动三联吻合器进行。支气管残端用网膜瓣覆盖。切除标本的病理显示完全缓解,肿瘤中间支气管与坏死腔之间有瘘管。他的术后过程顺利,术后10个月无疾病。
我们成功地对一名c-T4N2M0期IIIB期NSCLC患者进行了根治性CRT后的手术。使用自动三联吻合器安全地进行了部分左心房切除术。实现了对CRT的完全病理反应。在有机会进行完全(R0)切除的病例中,当发生致命并发症的风险可能超过CRT后手术围手术期并发症的风险时,应考虑将手术作为一种治疗选择。